VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 132 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,672 | -99.2% | 1,313 | -98.9% | 0.00% | – |
| Q2 2023 | $755,346 | -49.9% | 114,620 | -48.3% | 0.00% | -100.0% |
| Q1 2023 | $1,506,362 | +88.7% | 221,850 | +105.4% | 0.00% | 0.0% |
| Q4 2022 | $798,371 | -49.5% | 108,034 | -32.4% | 0.00% | 0.0% |
| Q3 2022 | $1,580,000 | +23.4% | 159,919 | +36.1% | 0.00% | 0.0% |
| Q2 2022 | $1,280,000 | +37.3% | 117,479 | +42.6% | 0.00% | 0.0% |
| Q1 2022 | $932,000 | -60.9% | 82,384 | -45.8% | 0.00% | 0.0% |
| Q4 2021 | $2,383,000 | +48.9% | 151,874 | +62.7% | 0.00% | 0.0% |
| Q3 2021 | $1,600,000 | -46.5% | 93,356 | -32.8% | 0.00% | -50.0% |
| Q2 2021 | $2,988,000 | +3.1% | 138,916 | -28.0% | 0.00% | 0.0% |
| Q1 2021 | $2,898,000 | +1223.3% | 192,936 | +1062.1% | 0.00% | – |
| Q4 2020 | $219,000 | +195.9% | 16,602 | +116.5% | 0.00% | – |
| Q3 2020 | $74,000 | -89.3% | 7,667 | -87.3% | 0.00% | -100.0% |
| Q2 2020 | $692,000 | +40.7% | 60,543 | +27.4% | 0.00% | – |
| Q1 2020 | $492,000 | -4.5% | 47,540 | +51.4% | 0.00% | – |
| Q4 2019 | $515,000 | -69.9% | 31,390 | -75.6% | 0.00% | -100.0% |
| Q3 2019 | $1,710,000 | -2.1% | 128,704 | +3.8% | 0.00% | 0.0% |
| Q2 2019 | $1,746,000 | +28.9% | 123,944 | +68.4% | 0.00% | 0.0% |
| Q1 2019 | $1,355,000 | -40.1% | 73,618 | -15.0% | 0.00% | -50.0% |
| Q4 2018 | $2,263,000 | +71.2% | 86,603 | +50.4% | 0.00% | +100.0% |
| Q3 2018 | $1,322,000 | +1147.2% | 57,592 | +931.2% | 0.00% | – |
| Q2 2018 | $106,000 | -38.0% | 5,585 | -44.8% | 0.00% | – |
| Q1 2018 | $171,000 | -88.2% | 10,125 | -89.4% | 0.00% | -100.0% |
| Q4 2017 | $1,448,000 | -41.9% | 95,271 | -31.6% | 0.00% | -50.0% |
| Q3 2017 | $2,494,000 | +204.9% | 139,353 | +177.8% | 0.00% | +100.0% |
| Q2 2017 | $818,000 | +27.2% | 50,163 | +9.3% | 0.00% | – |
| Q1 2017 | $643,000 | -72.0% | 45,900 | -68.1% | 0.00% | -100.0% |
| Q4 2016 | $2,295,000 | +353.6% | 143,887 | +372.5% | 0.00% | – |
| Q3 2016 | $506,000 | +406.0% | 30,455 | +241.2% | 0.00% | – |
| Q2 2016 | $100,000 | -69.7% | 8,926 | -77.4% | 0.00% | – |
| Q1 2016 | $330,000 | +345.9% | 39,540 | +397.9% | 0.00% | – |
| Q4 2015 | $74,000 | -86.3% | 7,942 | -83.4% | 0.00% | – |
| Q3 2015 | $540,000 | +248.4% | 47,839 | +291.8% | 0.00% | – |
| Q2 2015 | $155,000 | +98.7% | 12,209 | +45.1% | 0.00% | – |
| Q1 2015 | $78,000 | -64.4% | 8,413 | -45.0% | 0.00% | – |
| Q4 2014 | $219,000 | +1725.0% | 15,306 | +1198.2% | 0.00% | – |
| Q3 2014 | $12,000 | -83.1% | 1,179 | -73.1% | 0.00% | – |
| Q2 2014 | $71,000 | -49.3% | 4,389 | -48.9% | 0.00% | – |
| Q1 2014 | $140,000 | -13.6% | 8,588 | -34.4% | 0.00% | – |
| Q4 2013 | $162,000 | +58.8% | 13,095 | +40.6% | 0.00% | – |
| Q3 2013 | $102,000 | +385.7% | 9,311 | +271.4% | 0.00% | – |
| Q2 2013 | $21,000 | – | 2,507 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |